| AA | Arachidonic acid |
| ABC | ATP-binding cassette |
| ACSL4 | Acyl-CoA synthetase long-chain family member 4 |
| AdA | Adrenic acid |
| ADCs | Antibody-drug conjugates |
| AI | Artificial intelligence |
| AP | Apurinic/apyrimidinic |
| BCRP | Breast cancer resistance protein |
| BER | Base excision repair |
| c-FLIP | Cellular FLICE-like inhibitory protein |
| CHK | Csk homologous kinase |
| CMS | Consensus molecular subtypes |
| CRC | Colorectal cancers |
| CSC | Cancer stem cell |
| CTC | Circulating tumor cell |
| ctDNA | Circulating tumor DNA |
| CYP | Cytochrome P450 |
| DAMPs | Damage-associated molecular patterns |
| DCs | Dendritic cells |
| DFO | Deferoxamine |
| DMT1 | Divalent metal transporter 1 |
| DNMTi | DNA methyltransferase inhibitors |
| DNMTs | DNA methyltransferases |
| DOX | Doxorubicin |
| DSBs | Double-strand breaks |
| EMT | Epithelial–mesenchymal transition |
| EPR | Enhanced permeability and retention |
| ETC | Electron transport chain |
| FASN | Fatty acid synthase |
| FPN | Ferroportin |
| 5-FU | 5-fluorouracil |
| GCL | Glutamate-cysteine ligase |
| GPx | Glutathione peroxidase |
| GPX4 | Glutathione peroxidase 4 |
| GS | Glutathione synthetase |
| GSH | Glutathione |
| GSR | Glutathione reductase |
| GSSG | Oxidized glutathione |
| GSTs | Glutathione S-transferases |
| HCC | Hepatocellular carcinoma |
| HDACi | Histone deacetylase inhibitors |
| HDACs | Histone deacetylases |
| HMTs | Histone methyltransferases |
| HRD | Homologous recombination deficiency |
| HREs | Hypoxia response elements |
| HRR | Homologous recombination repair |
| LCN2 | Lipocalin 2 |
| LIP | Labile iron pool |
| LOOH | Lipid hydroperoxides |
| LOX | Lipoxygenase |
| LPCAT3 | Lysophosphatidylcholine acyltransferase 3 |
| MAPK | Mitogen-activated protein kinase |
| MDR | Multidrug resistance |
| MMR | Mismatch repair |
| MOMP | Mitochondrial outer membrane permeabilization |
| MRP1 | Multidrug resistance-associated protein 1 |
| MSI | Microsatellite instability |
| MUFAs | Monounsaturated fatty acids |
| NATs | N-acetyltransferases |
| NBDs | Nucleotide-binding domains |
| ncRNA | non-coding RNA |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NSCLC | Non-small-cell lung cancer |
| OTICs | Ovarian tumor-initiating cells |
| PARP | Poly (ADP-ribose) polymerase |
| PCET | Proton-coupled electron transfer |
| PDX | Patient-derived xenograft |
| PE | Phosphatidylethanolamine |
| PEBP1 | Phosphatidylethanolamine-binding protein 1 |
| PEG | Polyethylene glycol |
| P-gp | P-glycoprotein |
| PLGA | Poly (lactic-co-glycolic acid) |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 |
| PUFAs | Polyunsaturated fatty acids |
| PXR | Pregnane X receptor |
| ROS | Reactive oxygen species |
| SFAs | Saturated fatty acids |
| SOD | Superoxide dismutase |
| SQS | Squalene synthase |
| SREBP1 | Sterol regulatory element-binding protein 1 |
| SSBR | Single-strand break repair |
| SSBs | Single-strand breaks |
| SULTs | Sulfotransferases |
| TFR1 | Transferrin receptor 1 |
| TFRC | Transferrin receptor |
| TMDs | Transmembrane domains |
| TME | Tumor microenvironment |
| UGTs | UDP-glucuronosyltransferases |
| WES | Whole-exome sequencing |
| γ-GCS | γ-glutamylcysteine synthetase |